May 1, 2002 Issue of JAMA Neurology

May 2002, Vol 59, No. 5, Pages 681-880 | Neurotherapeutics 2002

Editorial

Experimental Neurotherapeutics: Leaps and Bounds

Ira Shoulson, MD

Abstract Full Text

Arch Neurol. 2002;59(5):689-691. doi:10.1001/archneur.59.5.689

Prospects for Vascular Endothelial Growth Factor Neurotherapeutics

David Pleasure, MD; Peter Bannerman, PhD; Jahan Ara, PhD; et al.

Abstract Full Text

Arch Neurol. 2002;59(5):692-694. doi:10.1001/archneur.59.5.692

Therapies for Movement Disorders

Christopher G. Goetz, MD; Vanessa K. Hinson, MD, PhD

Abstract Full Text

Arch Neurol. 2002;59(5):699-702. doi:10.1001/archneur.59.5.699

Treatment of Patients With Stroke

Louis R. Caplan, MD

Abstract Full Text

Arch Neurol. 2002;59(5):703-707. doi:10.1001/archneur.59.5.703

Viral Infections of the Nervous System, 2002: Update on Diagnosis and Treatment

John J. Redington, MD; Kenneth L. Tyler, MD

Abstract Full Text

Arch Neurol. 2002;59(5):712-718. doi:10.1001/archneur.59.5.712

Darts in the Dark Cure Animal, but Not Human, Brain Tumors

Hassan M. Fathallah-Shaykh, MD

Abstract Full Text

Arch Neurol. 2002;59(5):721-724. doi:10.1001/archneur.59.5.721

Current Immunotherapy for Demyelinating Diseases

Khurram Bashir, MD, MPH; John N. Whitaker, MD

Abstract Full Text

Arch Neurol. 2002;59(5):726-731. doi:10.1001/archneur.59.5.726

Therapy for the Epilepsies

Paul C. Van Ness, MD

Abstract Full Text

Arch Neurol. 2002;59(5):732-735. doi:10.1001/archneur.59.5.732

Therapies for Disorders of the Neuromuscular Junction

J. Ned Pruitt II, MD; Thomas R. Swift, MD

Abstract Full Text

Arch Neurol. 2002;59(5):739-742. doi:10.1001/archneur.59.5.739

Original Contribution

Diabetic Demyelinating Polyneuropathy Responsive to Intravenous Immunoglobulin Therapy

Khema R. Sharma, MD; John Cross, MD; D. Ram Ayyar, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):751-757. doi:10.1001/archneur.59.5.751

Demyelinating Neuropathy in Diabetes Mellitus

Khema R. Sharma, MD; John Cross, MD; Oscar Farronay, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):758-765. doi:10.1001/archneur.59.5.758

Efficacy of Intravenous Immunoglobulin in Patients With IgG Monoclonal Gammopathy and Polyneuropathy

Kenneth C. Gorson, MD; Allan H. Ropper, MD; David H. Weinberg, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):766-772. doi:10.1001/archneur.59.5.766

Methylprednisolone Acts on Peripheral Blood Mononuclear Cells and Endothelium in Inhibiting Migration Phenomena in Patients With Multiple Sclerosis

Maurizio Gelati, BS; Elena Corsini, BS; Marco De Rossi, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):774-780. doi:10.1001/archneur.59.5.774

Antiepileptic Drug鈥揑nduced Bone Loss in Young Male Patients Who Have Seizures

Dennis L. Andress, MD; Judy Ozuna, RN, MS; David Tirschwell, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):781-786. doi:10.1001/archneur.59.5.781

Plasma Homocysteine Levels, Cerebrovascular Risk Factors, and Cerebral White Matter Changes (Leukoaraiosis) in Patients With Alzheimer Disease

Eva Hogervorst, PhD; Helen Mendes Ribeiro, FRCR; Andrew Molyneux, FRCR; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):787-793. doi:10.1001/archneur.59.5.787

Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer Disease

Patrizia Mecocci, MD, PhD; M. Cristina Polidori, MD; Antonio Cherubini, MD, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):794-798. doi:10.1001/archneur.59.5.794

Budipine Provides Additional Benefit in Patients With Parkinson Disease Receiving a Stable Optimum Dopaminergic Drug Regimen

Horst Przuntek, MD; Stefan Bittkau, MD; Harald Bliesath, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):803-806. doi:10.1001/archneur.59.5.803

Refractory Nonmotor Symptoms in Male Patients With Parkinson Disease Due to Testosterone Deficiency: A Common Unrecognized Comorbidity

Michael S. Okun, MD; William M. McDonald, MD; Mahlon R. DeLong, MD

Abstract Full Text

free access

Arch Neurol. 2002;59(5):807-811. doi:10.1001/archneur.59.5.807

Risk Factors for Cognitive Impairment in HIV-1鈥揑nfected Persons With Different Risk Behaviors

Diana De Ronchi, MD; Irma Faranca, MD; Domenico Berardi, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):812-818. doi:10.1001/archneur.59.5.812

Contribution of the Interleukin 4 Gene to Susceptibility to Subacute Sclerosing Panencephalitis

Takehiko Inoue, MD; Ryutaro Kira, MD, PhD; Futoshi Nakao, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):822-827. doi:10.1001/archneur.59.5.822

Regional N-Acetylaspartate Reduction in the Hippocampus Detected With Fast Proton Magnetic Resonance Spectroscopic Imaging in Patients With Alzheimer Disease

Wolfgang Block, PhD; Frank Jessen, MD; Frank Träber, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):828-834. doi:10.1001/archneur.59.5.828

Brain Magnetic Resonance Imaging in Multiple-System Atrophy and Parkinson Disease: A Diagnostic Algorithm

Kirsty Bhattacharya, MD; Daniela Saadia, MD; Barbara Eisenkraft, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):835-842. doi:10.1001/archneur.59.5.835

Crossed Cerebellar Atrophy in Patients With Precocious Destructive Brain Insults

Ricardo A. Teixeira, MD; Li M. Li, MD, PhD; Sergio L. M. Santos, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):843-847. doi:10.1001/archneur.59.5.843

Familial Aggregation of Parkinson Disease: A Comparative Study of Early-Onset and Late-Onset Disease

Haydeh Payami, PhD; Sepideh Zareparsi, PhD; Dora James, BS; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):848-850. doi:10.1001/archneur.59.5.848

Images in Neurology

White Matter Changes in Wilson Disease

Peter Hedera, MD; George J. Brewer, MD; John K. Fink, MD

Abstract Full Text

Arch Neurol. 2002;59(5):866-867. doi:10.1001/archneur.59.5.866

Observation

Transient Visuospatial Disorder From Angiographic Contrast

Michael P. Merchut, MD; Bunnie Richie, DO

Abstract Full Text

free access

Arch Neurol. 2002;59(5):851-854. doi:10.1001/archneur.59.5.851

Autopsy-Proven, Sporadic Pick Disease With Onset at Age 25 Years

Landon W. Coleman, MD; Kathleen B. Digre, MD; Gary M. Stephenson, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):856-859. doi:10.1001/archneur.59.5.856

Cytochrome c Oxidase Deficiency Due to a Novel SCO2 Mutation Mimics Werdnig-Hoffmann Disease

Leonardo Salviati, MD; Sabrina Sacconi, MD; Minerva M. Rasalan, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):862-865. doi:10.1001/archneur.59.5.862

Book Reviews

Brain Tumors: An Encyclopedic Approach

Lisa M. DeAngelis, MD

Abstract Full Text

Arch Neurol. 2002;59(5):871. doi:

Contemporary Treatments in Neurology

George Paulson, MD

Abstract Full Text

Arch Neurol. 2002;59(5):871-872. doi:

NINDS at 50

Roger N. Rosenberg, MD

Abstract Full Text

Arch Neurol. 2002;59(5):872-873. doi:

This Month in Archives of Neurology

This Month in The Archives of Neurology

Abstract Full Text

free access

Arch Neurol. 2002;59(5):681-683. doi:10.1001/archneur.59.5.681

Neurological Review

Friedreich Ataxia: Effects of Genetic Understanding on Clinical Evaluation and Therapy

David R. Lynch, MD, PhD; Jennifer M. Farmer, MS; Laura J. Balcer, MD, MSCE; et al.

Abstract Full Text

free access

Arch Neurol. 2002;59(5):743-747. doi:10.1001/archneur.59.5.743

History of Neurology: Seminal Citations

Chorea Gravidarum

Francisco Cardoso, MD, PhD

Abstract Full Text

Arch Neurol. 2002;59(5):868-870. doi:10.1001/archneur.59.5.868

Letters to the Editor

Ocular Apraxia in Recessive Ataxia

Arnulf H. Koeppen, MD

Abstract Full Text

Arch Neurol. 2002;59(5):874. doi:

In reply

Paula Coutinho, MD, PhD; Clara Barbot, MD

Abstract Full Text

Arch Neurol. 2002;59(5):874. doi:

References for "History of Neurology: Seminal Citations" Series

Douglas J. Lanska, MD

Abstract Full Text

Arch Neurol. 2002;59(5):874-875. doi:

In reply

Christopher G. Goetz, MD

Abstract Full Text

Arch Neurol. 2002;59(5):874-875. doi:

Treatment of Sj枚gren Syndrome Myelopathy With Azathioprine and Steroids

Rollin James Hawley, MD; William T. Hendricks, MD

Abstract Full Text

Arch Neurol. 2002;59(5):875-876. doi:

In reply

Christopher S. Williams, USAF, MC; Gustavo C. Román, MD; Elizabeth Butler, MD

Abstract Full Text

Arch Neurol. 2002;59(5):875-876. doi:

Calendar

May-November 2002

Abstract Full Text

free access

Arch Neurol. 2002;59(5):877. doi:10.1001/archneur.59.5.877

Archives CME

Archives of Neurology Reader's Choice: Continuing Medical Education

Abstract Full Text

free access

Arch Neurol. 2002;59(5):878-880. doi:10.1001/archneur.59.5.878

October 2024 - July 1959

Decade

Year

Issue

May 2002, Vol 59, No. 5, Pages 681-880 | Neurotherapeutics 2002